“Third quarter performance tells a story of continued resilience and responsible execution as we delivered 5% revenue growth and 13% Adjusted EBITDA growth in a constrained demand environment,” said ...
All told, the Competition Bureau’s pet theory about veterinary prescription services is a dog’s breakfast of policy options and analysis. Vet costs are rising because of inflation and soaring demand ...